Insider · CIK 0001194712
George W Dunbar Jr
director
Files at CAPR (CAPRICOR THERAPEUTICS, INC.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | CAPR CAPRICOR THERAPEUTICS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +15,500 | $0.00 | $0 | 15,500 | Jan 7, 2026 |
| Dec 19, 2025 | CAPR CAPRICOR THERAPEUTICS, INC. | MOption exercise Common Stock | +3,000 | $1.39 | $4,170 | 14,306 | Dec 23, 2025 |
| Dec 19, 2025 | CAPR CAPRICOR THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative | -3,000 | $0.00 | $0 | 0 | Dec 23, 2025 |
| Mar 3, 2025 | CAPR CAPRICOR THERAPEUTICS, INC. | MOption exercise Common Stock | +750 | $1.39 | $1,043 | 11,306 | Mar 4, 2025 |
| Mar 3, 2025 | CAPR CAPRICOR THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative | -750 | $0.00 | $0 | 0 | Mar 4, 2025 |
| Jan 2, 2025 | CAPR CAPRICOR THERAPEUTICS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +11,940 | $0.00 | $0 | 11,940 | Jan 6, 2025 |
| Jan 2, 2025 | CAPR CAPRICOR THERAPEUTICS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +3,600 | $0.00 | $0 | 3,600 | Jan 6, 2025 |
| Jan 2, 2025 | CAPR CAPRICOR THERAPEUTICS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +5,750 | $0.00 | $0 | 5,750 | Jan 6, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.